Comprehensive AI Planning for Successful Product Launches
‍
Target Product Planning (TPP) – Plan, conduct, and internally communicate TPP activities appropriate to the program/product stage of
development, including competitive intelligence, therapeutic indication prioritization, development of  Target Product Profiles
(TPPs), and primary and secondary market research. We utilize TPP to provide research recommendations on therapeutic drug programs
from the preclinical through clinical stages which leads to product launches that are executed seamlessly.

Launch Excellence through creative
Go-to-Market Strategies

With deep experience in go-to-market strategies, we help navigate the competitive landscape for accurate product sales and marketing.

We prioritize full integration and engagement of stakeholders' continuity. These include Health Care Providers, Payers, Key Opinion Leaders, and Channel Decision Makers.

We offer strategic recommendations to enhance early product positioning, preliminary pricing, and messaging in order to effectively differentiate from competitors. Our expertise allows us to optimize these critical aspects, capitalizing on your market potential.

Maximize Real World AI Analytics Supported Evidence

Through the use of our custom analytics based on formulary and claims data, we offer insight into the dynamics of access. With this knowledge, patient affordability programs can be designed, payer/provider engagement strategies can be formulated, and account-level contracting tactics can be optimized.

To gain a more intricate comprehension of the patient experience and tap into potential markets, we maximize analytics at the patient level. In addition, we use data evidence to provide predictive methods for locating patients with challenging healthcare.

Maximize payer landscape relationships to create ease-to-market access

To find the most pertinent stakeholders, formularies, and reimbursement policies, USPC conducts a thorough AI analysis of the global payer environment.

We offer experience and research on the landscape to enhance your business decisions.

With strategic planning and in-depth AI payer market research, we use a collaborative approach for our clients.

Maximizing Commercial Success through Payer Landscape

We identify access objectives that support overall commercial success using our analytical and strategic business experience.

We utilize medical affairs directives to assist with strategic guidance. This enhances health technology assessments and leads to successful product launches and market access.

We increase product success by reducing any reimbursement hurdles through a time-tested creative pricing and compendium approach.

Gaining access for proper forecasting outcomes through innovative price modeling and contract implementation
‍
We develop and implement time-tested pricing and contract business approaches that are relevant to the real-time market landscape for optimal outcomes.

By utilizing analog competitive pricing, market intel, and analytical practices, including market analysis, we maximize profitability.

Our pricing models are supported by years of experience with positive payer outcomes.

Creating "Access for Success" Optimization

USPC identifies unmet product needs and coverage gaps in reimbursement systems creating a competitive edge for successful product launches and payer access for our clients.

Our clients benefit from a comprehensive real-world business approach for developing, utilizing, and enhancing your value proposition through AI,
real-time data and economics minimizing coverage gaps and maximizing critical opportunities within the payer landscape.

External stakeholder engagement which aligns with payers, providers, patients, policymakers, and other key entities, provides a gateway for all access needs, expectations, and mutually beneficial business outcomes. USPC's expertise assists with developing critical strategies for success with these stakeholders.

Our mission is creating product and patient access through revolutionary business metrics.

USPC offers experience and AI expertise with patient-centric strategies prior to product launch. This enhances the patient journey and health outcomes post-product launch.

Maximizing USPC's AI platform, internal stakeholder's skill set and business relationships bridging the gap between the patient's hub and specialty distribution/pharmacy as integrated partners, which creates end-to-end support throughout the patient treatment journey.
‍
USPC will eliminate the mystery behind hubs to ease the patient treatment process. Our client enjoys a simplified path for patients to gain access to their treatment by creating a cohesive alliance and benefit for all stakeholders, including manufacturers, wholesalers, distributors, physicians, pharmacies, and patients.

Proper clinical trial composition with the payer decision markers protocol in mind

USPC offers insight for our clients (manufacturers) to develop a more effective clinical and regulatory pathway by keeping the payer's business requirements at the forefront during clinical trial design with a focus on cost avoidance.

By utilizing USPC's dynamic business network and AI real-world data connection, we can model patient and payer outcomes at proof of concept and clinical trial development. USPC understands "molecule to market" and most importantly "market reimbursement back to molecule."